Physiol Rev AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Rev. 85: 1-31, 2005; doi:10.1152/physrev.00048.2003
0031-9333/05 $18.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (187)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newby, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newby, A. C.

Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture

Andrew C. Newby

Bristol Heart Institute, University of Bristol, Bristol, United Kingdom

Intimal thickening, the accumulation of cells and extracellular matrix within the inner vessel wall, is a physiological response to mechanical injury, increased wall stress, or chemical insult (e.g., atherosclerosis). If excessive, it can lead to the obstruction of blood flow and tissue ischemia. Together with expansive or constrictive remodeling, the extent of intimal expansion determines final lumen size and vessel wall thickness. Plaque rupture represents a failure of intimal remodeling, where the fibrous cap overlying an atheromatous core of lipid undergoes catastrophic mechanical breakdown. Plaque rupture promotes coronary thrombosis and myocardial infarction, the most prevalent cause of premature death in advanced societies. The matrix metalloproteinases (MMPs) can act together to degrade the major components of the vascular extracellular matrix. All cells present in the normal and diseased blood vessel wall upregulate and activate MMPs in a multistep fashion driven in part by soluble cytokines and cell-cell interactions. Activation of MMP proforms requires other MMPs or other classes of protease. MMP activation contributes to intimal growth and vessel wall remodeling in response to injury, most notably by promoting migration of vascular smooth muscle cells. A broader spectrum and/or higher level of MMP activation, especially associated with inflammation, could contribute to pathological matrix destruction and plaque rupture. Inhibiting the activity of specific MMPs or preventing their upregulation could ameliorate intimal thickening and prevent myocardial infarction.





This article has been cited by other articles:


Home page
Circ. Res.Home page
Z. Mallat
Matrix Metalloproteinase-8 and the Regulation of Blood Pressure, Vascular Inflammation, and Atherosclerotic Lesion Growth
Circ. Res., October 23, 2009; 105(9): 827 - 829.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-D. Shi, X.-Y. Ji, H. Qazi, and J. M. Tarbell
Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1225 - H1234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Rizzo
Enhanced interstitial flow as a contributing factor in neointima formation: (shear) stressing vascular wall cell types other than the endothelium
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1196 - H1197.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Jiang, M. Tao, K. A. Omalley, D. Wang, C. K. Ozaki, and S. A. Berceli
Established neointimal hyperplasia in vein grafts expands via TGF-{beta}-mediated progressive fibrosis
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1200 - H1207.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
Y.-C. Cheng, W.-H. L. Kao, B. D. Mitchell, J. R. O'Connell, H. Shen, P. F. McArdle, Q. Gibson, K. A. Ryan, A. R. Shuldiner, and T. I. Pollin
Genome-Wide Association Scan Identifies Variants near Matrix Metalloproteinase (MMP) Genes on Chromosome 11q21-22 Strongly Associated With Serum MMP-1 Levels
Circ Cardiovasc Genet, August 1, 2009; 2(4): 329 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Goyette, W. X. Yan, E. Yamen, Y. M. Chung, S. Y. Lim, K. Hsu, F. Rahimi, N. Di Girolamo, C. Song, W. Jessup, et al.
Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture
J. Immunol., July 1, 2009; 183(1): 593 - 603.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Ohshima, A. Petrov, S. Fujimoto, J. Zhou, M. Azure, D. S. Edwards, T. Murohara, N. Narula, S. Tsimikas, and J. Narula
Molecular Imaging of Matrix Metalloproteinase Expression in Atherosclerotic Plaques of Mice Deficient in Apolipoprotein E or Low-Density-Lipoprotein Receptor
J. Nucl. Med., April 1, 2009; 50(4): 612 - 617.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. K. Lund, J. Lucero, S. Lucas, M. C. Madden, J. D. McDonald, J.-C. Seagrave, T. L. Knuckles, and M. J. Campen
Vehicular Emissions Induce Vascular MMP-9 Expression and Activity Associated With Endothelin-1-Mediated Pathways
Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 511 - 517.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Hlawaty, M.-P. Jacob, L. Louedec, D. Letourneur, C. Brink, J.-B. Michel, L. Feldman, and M. Back
Leukotriene Receptor Antagonism and the Prevention of Extracellular Matrix Degradation During Atherosclerosis and In-Stent Stenosis
Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 518 - 524.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Mack, Y. Zhang, S. Chung, V. Vickerman, R. D. Kamm, and G. Garcia-Cardena
Biomechanical Regulation of Endothelium-dependent Events Critical for Adaptive Remodeling
J. Biol. Chem., March 27, 2009; 284(13): 8412 - 8420.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
E. Adiguzel, P. J Ahmad, C. Franco, and M. P Bendeck
Collagens in the progression and complications of atherosclerosis
Vascular Medicine, February 1, 2009; 14(1): 73 - 89.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. de Nooijer, I. Bot, J.H. von der Thusen, M.A. Leeuwenburgh, H.S. Overkleeft, A.O. Kraaijeveld, R. Dorland, P.J. van Santbrink, S.H. van Heiningen, M.M. Westra, et al.
Leukocyte Cathepsin S Is a Potent Regulator of Both Cell and Matrix Turnover in Advanced Atherosclerosis
Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 188 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Straat, R. de Klark, S. Gredmark-Russ, P. Eriksson, and C. Soderberg-Naucler
Infection with Human Cytomegalovirus Alters the MMP-9/TIMP-1 Balance in Human Macrophages
J. Virol., January 15, 2009; 83(2): 830 - 835.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Caporali and C. Emanueli
Cardiovascular Actions of Neurotrophins
Physiol Rev, January 1, 2009; 89(1): 279 - 308.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Tarin, M. Gomez, E. Calvo, J. A. Lopez, and C. Zaragoza
Endothelial Nitric Oxide Deficiency Reduces MMP-13-Mediated Cleavage of ICAM-1 in Vascular Endothelium: A Role in Atherosclerosis
Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 27 - 32.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. Leoni, H. B. Patel, A. L. F. Sampaio, F. N. E. Gavins, J. F. Murray, P. Grieco, S. J. Getting, and M. Perretti
Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion
FASEB J, December 1, 2008; 22(12): 4228 - 4238.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Newby
Metalloproteinase Expression in Monocytes and Macrophages and its Relationship to Atherosclerotic Plaque Instability
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2108 - 2114.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Zhang, L. Nie, M. Razavian, M. Ahmed, L. W. Dobrucki, A. Asadi, D. S. Edwards, M. Azure, A. J. Sinusas, and M. M. Sadeghi
Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling
Circulation, November 4, 2008; 118(19): 1953 - 1960.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. L. Yu, R. Fuchshofer, A. Kampik, and U. Welge-Lussen
Effects of Oxidative Stress in Trabecular Meshwork Cells Are Reduced by Prostaglandin Analogues
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4872 - 4880.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-F. Cailhier, I. Sirois, P. Laplante, S. Lepage, M.-A. Raymond, N. Brassard, A. Prat, R. V. Iozzo, A. V. Pshezhetsky, and M.-J. Hebert
Caspase-3 Activation Triggers Extracellular Cathepsin L Release and Endorepellin Proteolysis
J. Biol. Chem., October 3, 2008; 283(40): 27220 - 27229.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. A. Maile, B. E. Capps, E. C. Miller, A. W. Aday, and D. R. Clemmons
Integrin-Associated Protein Association With Src Homology 2 Domain Containing Tyrosine Phosphatase Substrate 1 Regulates IGF-I Signaling In Vivo
Diabetes, October 1, 2008; 57(10): 2637 - 2643.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Johnson, G. B. Sala-Newby, Y. Ismail, C. M. Aguilera, and A. C. Newby
Low Tissue Inhibitor of Metalloproteinases 3 and High Matrix Metalloproteinase 14 Levels Defines a Subpopulation of Highly Invasive Foam-Cell Macrophages
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1647 - 1653.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Croons, W. Martinet, A. G. Herman, and G. R. Y. De Meyer
Differential Effect of the Protein Synthesis Inhibitors Puromycin and Cycloheximide on Vascular Smooth Muscle Cell Viability
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 824 - 832.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Braunersreuther, S. Steffens, C. Arnaud, G. Pelli, F. Burger, A. Proudfoot, and F. Mach
A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1090 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. W.M. van Hinsbergh and P. Koolwijk
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
Cardiovasc Res, May 1, 2008; 78(2): 203 - 212.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. Diamanti-Kandarakis, S. Livadas, S. A Kandarakis, A. Margeli, and I. Papassotiriou
Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
Eur. J. Endocrinol., April 1, 2008; 158(4): 525 - 531.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Mannello
Serum or Plasma Samples?: The "Cinderella" Role of Blood Collection Procedures Preanalytical Methodological Issues Influence the Release and Activity of Circulating Matrix Metalloproteinases and Their Tissue Inhibitors, Hampering Diagnostic Trueness and Leading to Misinterpretation
Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 611 - 614.
[Full Text] [PDF]


Home page
DiabetesHome page
G. Boden, W. Song, L. Pashko, and K. Kresge
In Vivo Effects of Insulin and Free Fatty Acids on Matrix Metalloproteinases in Rat Aorta
Diabetes, February 1, 2008; 57(2): 476 - 483.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. T.Y. Li, K. E. Swales, G. J. Thomas, T. D. Warner, and D. Bishop-Bailey
Farnesoid X Receptor Ligands Inhibit Vascular Smooth Muscle Cell Inflammation and Migration
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2606 - 2611.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. P. M. Lutgens, K. B. J. M. Cleutjens, M. J. A. P. Daemen, and S. Heeneman
Cathepsin cysteine proteases in cardiovascular disease
FASEB J, October 1, 2007; 21(12): 3029 - 3041.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. C.M. Siow and A. T. Churchman
Adventitial growth factor signalling and vascular remodelling: Potential of perivascular gene transfer from the outside-in
Cardiovasc Res, September 1, 2007; 75(4): 659 - 668.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Song, A. L. Mowbray, M. C. Sykes, and H. Jo
Emerging Role of IGF-1R in Stretch-Induced Neointimal Hyperplasia in Venous Grafts
Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1679 - 1681.
[Full Text] [PDF]


Home page
HypertensionHome page
G. Gavazzi, C. Deffert, C. Trocme, M. Schappi, F. R. Herrmann, and K.-H. Krause
NOX1 Deficiency Protects From Aortic Dissection in Response to Angiotensin II
Hypertension, July 1, 2007; 50(1): 189 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. J. Wu, N. Di Girolamo, K. Beck, C. G. Hanratty, K. Choy, J. Y. Hou, M. R. Ward, and R. Stocker
Probucol [4,4'-[(1-Methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]] Inhibits Compensatory Remodeling and Promotes Lumen Loss Associated with Atherosclerosis in Apolipoprotein E-Deficient Mice
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
H. J. Cho, P. Shashkin, C. A. Gleissner, D. Dunson, N. Jain, J. K. Lee, Y. Miller, and K. Ley
Induction of dendritic cell-like phenotype in macrophages during foam cell formation
Physiol Genomics, April 24, 2007; 29(2): 149 - 160.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kitamoto, G. K. Sukhova, J. Sun, M. Yang, P. Libby, V. Love, P. Duramad, C. Sun, Y. Zhang, X. Yang, et al.
Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Knockout Mice
Circulation, April 17, 2007; 115(15): 2065 - 2075.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Tellier, A. Negre-Salvayre, B. Bocquet, S. Itohara, Y. A. Hannun, R. Salvayre, and N. Auge
Role for Furin in Tumor Necrosis Factor Alpha-Induced Activation of the Matrix Metalloproteinase/Sphingolipid Mitogenic Pathway
Mol. Cell. Biol., April 15, 2007; 27(8): 2997 - 3007.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Li, J. Liang, D. H. Castrillon, R. A. DePinho, E. N. Olson, and Z.-P. Liu
FoxO4 Regulates Tumor Necrosis Factor Alpha-Directed Smooth Muscle Cell Migration by Activating Matrix Metalloproteinase 9 Gene Transcription
Mol. Cell. Biol., April 1, 2007; 27(7): 2676 - 2686.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Johannsson, T. Henriksen, and P. O. Iversen
Increase in matrix metalloproteinases from endothelial cells exposed to umbilical cord plasma from high birth weight newborns
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1563 - R1568.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Martinet and G. R.Y. De Meyer
Selective Depletion of Macrophages in Atherosclerotic Plaques: Myth, Hype, or Reality?
Circ. Res., March 30, 2007; 100(6): 751 - 753.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Croons, W. Martinet, A. G. Herman, J.-P. Timmermans, and G. R. Y. De Meyer
Selective Clearance of Macrophages in Atherosclerotic Plaques by the Protein Synthesis Inhibitor Cycloheximide
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 986 - 993.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. O. Platt, R. F. Ankeny, G.-P. Shi, D. Weiss, J. D. Vega, W. R. Taylor, and H. Jo
Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1479 - H1486.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Wan, N. Shukla, A. P.C. Yim, J. L. Johnson, G. D. Angelini, and J. Y. Jeremy
Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts
J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 494 - 500.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. K. Lund, T. L. Knuckles, C. Obot Akata, R. Shohet, J. D. McDonald, A. Gigliotti, J. C. Seagrave, and M. J. Campen
Gasoline Exhaust Emissions Induce Vascular Remodeling Pathways Involved in Atherosclerosis
Toxicol. Sci., February 1, 2007; 95(2): 485 - 494.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. J. Greenlee, Z. Werb, and F. Kheradmand
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Physiol Rev, January 1, 2007; 87(1): 69 - 98.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Aoki, H. Kataoka, M. Morimoto, K. Nozaki, and N. Hashimoto
Macrophage-Derived Matrix Metalloproteinase-2 and -9 Promote the Progression of Cerebral Aneurysms in Rats
Stroke, January 1, 2007; 38(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
R. A Ajjan and P. J Grant
Cardiovascular disease prevention in patients with type 2 diabetes: the role of oral anti-diabetic agents
Diabetes and Vascular Disease Research, December 1, 2006; 3(3): 147 - 158.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
D.-x. Bu, A.-L. Hemdahl, A. Gabrielsen, J. Fuxe, C. Zhu, P. Eriksson, and Z.-q. Yan
Induction of Neutrophil Gelatinase-Associated Lipocalin in Vascular Injury via Activation of Nuclear Factor-{kappa}B
Am. J. Pathol., December 1, 2006; 169(6): 2245 - 2253.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. M. Risinger Jr., T. S. Hunt, D. L. Updike, E. C. Bullen, and E. W. Howard
Matrix Metalloproteinase-2 Expression by Vascular Smooth Muscle Cells Is Mediated by Both Stimulatory and Inhibitory Signals in Response to Growth Factors
J. Biol. Chem., September 8, 2006; 281(36): 25915 - 25925.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Goerge, A. Barg, E.-M. Schnaeker, B. Poppelmann, V. Shpacovitch, A. Rattenholl, C. Maaser, T. A. Luger, M. Steinhoff, and S. W. Schneider
Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation.
Cancer Res., August 1, 2006; 66(15): 7766 - 7774.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. M. Mallawaarachchi, P. L. Weissberg, and R. C. M. Siow
Antagonism of platelet-derived growth factor by perivascular gene transfer attenuates adventitial cell migration after vascular injury: new tricks for old dogs?
FASEB J, August 1, 2006; 20(10): 1686 - 1688.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Nilsson, L. Jonasson, J. Nijm, A. Hamsten, and P. Eriksson
Increased Plasma Concentration of Matrix Metalloproteinase-7 in Patients with Coronary Artery Disease
Clin. Chem., August 1, 2006; 52(8): 1522 - 1527.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. von Wnuck Lipinski, P. Keul, N. Ferri, S. Lucke, G. Heusch, J. W. Fischer, and B. Levkau
Integrin-Mediated Transcriptional Activation of Inhibitor of Apoptosis Proteins Protects Smooth Muscle Cells Against Apoptosis Induced by Degraded Collagen
Circ. Res., June 23, 2006; 98(12): 1490 - 1497.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. Vigetti, P. Moretto, M. Viola, A. Genasetti, M. Rizzi, E. Karousou, F. Pallotti, G. De Luca, and A. Passi
Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging
FASEB J, June 1, 2006; 20(8): 1118 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Martinet, G. R. Y. De Meyer, J.-P. Timmermans, A. G. Herman, and M. M. Kockx
Macrophages but Not Smooth Muscle Cells Undergo Benzyloxycarbonyl-Val-Ala-DL-Asp(O-Methyl)-Fluoromethylketone-Induced Nonapoptotic Cell Death Depending on Receptor-Interacting Protein 1 Expression: Implications for the Stabilization of Macrophage-Rich Atherosclerotic Plaques
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1356 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Fiotti, N. Altamura, M. Fisicaro, N. Carraro, L. Uxa, G. Grassi, L. Torelli, R. Gobbato, G. Guarnieri, B. T. Baxter, et al.
MMP-9 Microsatellite Polymorphism and Susceptibility to Carotid Arteries Atherosclerosis
Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1330 - 1336.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. L. Johnson, A. H. Baker, K. Oka, L. Chan, A. C. Newby, C. L. Jackson, and S. J. George
Suppression of Atherosclerotic Plaque Progression and Instability by Tissue Inhibitor of Metalloproteinase-2: Involvement of Macrophage Migration and Apoptosis
Circulation, May 23, 2006; 113(20): 2435 - 2444.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Franco, B. Ho, D. Mulholland, G. Hou, M. Islam, K. Donaldson, and M. P. Bendeck
Doxycycline Alters Vascular Smooth Muscle Cell Adhesion, Migration, and Reorganization of Fibrillar Collagen Matrices
Am. J. Pathol., May 1, 2006; 168(5): 1697 - 1709.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Kuzuya, K. Nakamura, T. Sasaki, X. Wu Cheng, S. Itohara, and A. Iguchi
Effect of MMP-2 Deficiency on Atherosclerotic Lesion Formation in ApoE-Deficient Mice
Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1120 - 1125.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Tjwa, P. Carmeliet, and L. Moons
Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Circulation, April 25, 2006; 113(16): 1929 - 1932.
[Full Text] [PDF]


Home page
CirculationHome page
J. Liang, E. Liu, Y. Yu, S. Kitajima, T. Koike, Y. Jin, M. Morimoto, K. Hatakeyama, Y. Asada, T. Watanabe, et al.
Macrophage Metalloelastase Accelerates the Progression of Atherosclerosis in Transgenic Rabbits
Circulation, April 25, 2006; 113(16): 1993 - 2001.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Devel, V. Rogakos, A. David, A. Makaritis, F. Beau, P. Cuniasse, A. Yiotakis, and V. Dive
Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12
J. Biol. Chem., April 21, 2006; 281(16): 11152 - 11160.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Menshikov, O. Plekhanova, H. Cai, K. Chalupsky, Y. Parfyonova, P. Bashtrikov, V. Tkachuk, and B. C. Berk
Urokinase Plasminogen Activator Stimulates Vascular Smooth Muscle Cell Proliferation Via Redox-Dependent Pathways
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 801 - 807.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax
Pericellular Proteases in Angiogenesis and Vasculogenesis
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 716 - 728.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Nagase, R. Visse, and G. Murphy
Structure and function of matrix metalloproteinases and TIMPs
Cardiovasc Res, February 15, 2006; 69(3): 562 - 573.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. P.G. Sluijter, D. P.V. de Kleijn, and G. Pasterkamp
Vascular remodeling and protease inhibition-bench to bedside
Cardiovasc Res, February 15, 2006; 69(3): 595 - 603.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. C. Newby
Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates
Cardiovasc Res, February 15, 2006; 69(3): 614 - 624.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. M. Dollery and P. Libby
Atherosclerosis and proteinase activation
Cardiovasc Res, February 15, 2006; 69(3): 625 - 635.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Ye
Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome
Cardiovasc Res, February 15, 2006; 69(3): 636 - 645.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. von Wnuck Lipinski, P. Keul, S. Lucke, G. Heusch, J. Wohlschlaeger, H. A. Baba, and B. Levkau
Degraded collagen induces calpain-mediated apoptosis and destruction of the X-chromosome-linked inhibitor of apoptosis (xIAP) in human vascular smooth muscle cells
Cardiovasc Res, February 15, 2006; 69(3): 697 - 705.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. C. Newby and J. L. Johnson
Genetic Strategies to Elucidate the Roles of Matrix Metalloproteinases in Atherosclerotic Plaque Growth and Stability
Circ. Res., November 11, 2005; 97(10): 958 - 960.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. L. Johnson, S. J. George, A. C. Newby, and C. L. Jackson
Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries
PNAS, October 25, 2005; 102(43): 15575 - 15580.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.